Global Generic Drug Affairs team issues one-year progress report
July 28 - Highlights activities and accomplishments of Generic Drug Cluster
Drugs
The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United States
Topic Paragraphs
Recent News
CDER expert discusses drug quality sampling and testing program
July 20 - Mission is to ensure quality medicines are available to consumers
New podcast series answers FDA’s most commonly asked questions
July 20 - In this month’s episode, CDER expert discusses Paxlovid and COVID-19
Upcoming Events
CDER to highlight FDA’s role in international regulatory harmonization
Emphasis on strengthening systems in low- and middle-income countries
FDA to clarify practical considerations for generic drug applicants
Focus on in vitro characterization-based BE approaches for topical drugs
FDA to review guidance on generic drug pH adjusters waiver requests
Specific to drug products intended for parenteral, ophthalmic or otic use
Trending Topics
Disposal of Unused Medicines: What You Should Know
The short video shows you how to properly get rid of unused or expired medication
High Blood Pressure–Understanding the Silent Killer
It can lead to many serious problems that’s why it’s important to know your risk factors
BeSafeRx: Your Source for Online Pharmacy Information
Explore resources and tools so you can safely buy prescription medicines online
CENTER FOR DRUG EVALUATION AND RESEARCH
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
Toll Free
(855) 543-3784
(301) 796-3400
Hours Available
CDER Division of Drug Information
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
@FDA_Drug_Info
Your source for the latest drug information.
Know the moment it happens.